What does the presence of stool in a Ryle's (nasogastric) tube suggest in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Stool in Ryle's Tube: Clinical Significance

The presence of stool in a nasogastric (Ryle's) tube indicates a gastrocolocutaneous fistula—an abnormal connection between the stomach, colon, and potentially the skin—which is a serious complication requiring immediate surgical evaluation. 1

Primary Pathophysiology

The most common mechanism involves inadvertent colon perforation during gastrostomy tube placement, or subsequent erosion of the feeding tube into adjacent colon. 1 This creates a fistulous tract allowing colonic contents to reflux into the stomach and subsequently drain through the nasogastric tube.

Key clinical presentations include:

  • Stool or feculent material draining from the nasogastric tube 1
  • Diarrhea resembling enteral formula during feeding (when a gastrostomy is present) 1
  • Stool leaking around a gastrostomy tube site 1

Immediate Diagnostic Steps

Obtain CT abdomen/pelvis with IV contrast immediately to confirm the fistula and assess for complications such as peritonitis or abscess formation. 2 This imaging modality has >90% diagnostic accuracy for identifying abnormal bowel connections and associated complications. 2

Check for signs of peritonitis or sepsis:

  • Fever, tachycardia, hypotension 3
  • Diffuse abdominal tenderness, guarding, or rebound 3
  • Leukocytosis >10,000/mm³ 2
  • Elevated lactate levels suggesting bowel ischemia 2, 3

Management Algorithm

For acute presentation with peritonitis or hemodynamic instability:

  • Immediate surgical consultation for exploratory laparotomy 1
  • Broad-spectrum antibiotics 1
  • Aggressive fluid resuscitation with crystalloids 2
  • Keep patient NPO with nasogastric decompression 1

For stable patients without peritonitis:

  • Remove the offending tube (gastrostomy or nasogastric) 1
  • Most fistulas will close spontaneously after tube removal 1
  • Maintain nasogastric suction if gastrostomy is removed 1
  • Administer broad-spectrum antibiotics 1
  • Monitor closely for 7-10 days 1

Critical Pitfalls to Avoid

Do not attempt to replace or manipulate the tube if a gastrocolocutaneous fistula is suspected, as this can worsen the fistula or cause perforation. 1

Do not delay surgical consultation when signs of peritonitis are present, as mortality increases significantly with delayed intervention. 2 Mortality can reach 25-30% with bowel necrosis or perforation. 2

Distinguish from small bowel obstruction with feculent vomiting: While the "small bowel faeces sign" can occur in bowel obstruction, stool actually draining through a properly positioned nasogastric tube (confirmed to be in the stomach) specifically indicates a fistula rather than simple obstruction. 4 In obstruction, feculent material represents bacterial overgrowth in stagnant small bowel contents, not actual colonic stool. 3

Prevention Strategies

When placing gastrostomy tubes, use the "safe-track" technique with adequate gastric insufflation and elevation of the head of bed to displace the colon inferiorly away from the puncture site. 1 This significantly reduces the risk of inadvertent colon perforation during initial placement.

Surgical Intervention Requirements

Surgery is rarely needed if the fistula is recognized early and the tube is removed promptly. 1 However, immediate surgical exploration is mandatory for:

  • Signs of peritonitis or sepsis 1
  • Hemodynamic instability 5
  • Failure of the fistula to close after conservative management 1
  • Development of intra-abdominal abscess 2

Related Questions

What are the best practices for increasing the rate of enteral feedings?
What is the recommended amount and frequency of Ensure (nutritional supplement) for patients with Percutaneous Endoscopic Gastrostomy (PEG) tube feedings?
Can the external anal sphincter and puborectalis be trained to relax when they are compensating for reduced internal anal sphincter tone in an adult male, and is that compensation necessary for continence?
Can a patient with a Percutaneous Endoscopic Gastrostomy (PEG) tube feed orally?
Should the nasogastric (NG) tube be clamped when introducing oral fluids to a patient with intestinal pseudoobstruction or ileus who has shown clinical improvement with nasogastric tube to suction and rectal tube?
What is the recommended maintenance dose of Pentasa (mesalamine) for a typical adult patient with mild to moderate ulcerative colitis?
When should elevated Thyroid-Stimulating Hormone (TSH) levels be treated in adults, including older adults and pregnant women?
Can ipratropium bromide (anticholinergic nasal spray) be combined with Ryaltris (azelastine/fluticasone) in a patient with a history of rhinitis and potential allergies?
Will adding ipratropium bromide to Ryaltris (azelastine and fluticasone) help alleviate postnasal drip in a patient with a history of rhinitis and potential allergies?
What is the differential diagnosis for a skin lesion with histopathological features of psoriasiform hyperplasia, orthokeratosis, neutrophil collection in stratum corneum, and mild superficial perivascular and peradnexal lymphocytic infiltrate, with a retained granular layer?
What is the appropriate use and dosage of prednisone for a moderately asthmatic adult patient with a viral infection, post-nasal drip, and cough?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.